简体中文

Popular search

Recently visited pages

    Back to News
    ARC Capital in the Australia-China biotech invest
    News | 12 April, 2017

    ARC Capital in the Australia-China biotech invest

    Last Monday, ARC Capital was involved in the Australia-China biotech invest 2017, the place to find Biotech innovators from around the world and partnership opportunities. with leading-edge technologies.

    The program took place on Monday 27 March at the Marriott in Shanghai. The program featured company presentations, keynote speakers, lively panel discussions and was the perfect location for us to meet potential clients.

    We discuss with the following companies in order to cooperate together:

    • Petri Exchange
    • Biotron
    • Novogen
    • FivepHusion
    • ResApp

    The upcoming partnerships is an indication of ARC Capital’s capabilities to assist both public and private listed companies.

    Continue reading

    ARC Group Promotes Charlene Lui to Director
    News | 10 August, 2026

    ARC Group Promotes Charlene Lui to Director

    ARC Group is pleased to announce the promotion of Charlene Lui to Director. Based in Hong Kong, Charlene is a member of the firm’s M&A team, where she has built a track record of originating and overseeing new business opportunities and client engagements from initial pitch through transaction closing, helping drive ARC Group’s deal pipeline […]
    2026 Capital Markets and M&A Forum Returns to the Bund in Shanghai This Fall, Spotlighting Overseas Listings, Cross-Border M&A, and the Global Expansion of Chinese Enterprises
    News | 06 August, 2026

    2026 Capital Markets and M&A Forum Returns to the Bund in Shanghai This Fall, Spotlighting Overseas Listings, Cross-Border M&A, and the Global Expansion of Chinese Enterprises

    Shanghai, China, August 5, 2026 – ARC Group, a global investment bank and management consulting firm, today announced that the Capital Markets and M&A Forum 2026: China Edition will take place on September 3, 2026, at the Waldorf Astoria Shanghai on the Bund. This event brings together founders, executives, investors, and professional advisors to explore […]
    ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)
    News | 09 July, 2026

    ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

    HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
    Rising Together | ARC Dragon Boat Team Takes to the Water
    News | 18 June, 2026

    Rising Together | ARC Dragon Boat Team Takes to the Water

    As the Dragon Boat Festival comes around again, so do its oldest rhythms: the long hulls slicing through water, the steady beat of the drum, a crew pulling as one. It is a festival about resilience and forward drive and about finding a shared cadence with the people sitting beside you in the same boat. […]

    Please complete this form to download the case study

    This field is for validation purposes and should be left unchanged.
    (Required)
    *Required before submission